Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Treatment of Insomnia in Postmenopausal Women

First-Line Treatment: Non-Pharmacological Approaches

  • The American Academy of Sleep Medicine recommends Cognitive Behavioral Therapy for Insomnia (CBT-I) as the most effective evidence-based treatment for chronic insomnia in older adults, including postmenopausal women, with sustained effects for up to 2 years 4
  • CBT-I components that should be implemented include sleep restriction/compression therapy, stimulus control, sleep hygiene education, and cognitive restructuring to address unhelpful beliefs about sleep 4

Second-Line Treatment: Pharmacological Options

  • For sleep onset insomnia, the American Geriatrics Society suggests considering ramelteon (melatonin receptor agonist) or short-acting non-benzodiazepine receptor agonists (Z-drugs) at the lowest effective dose 5
  • For sleep maintenance insomnia, low-dose doxepin (3-6mg) is effective with minimal side effects in older adults 1
  • The American Academy of Sleep Medicine recommends considering suvorexant (orexin receptor antagonist) for sleep maintenance issues, and eszopiclone or extended-release zolpidem at the lowest effective dose for both onset and maintenance insomnia 4

Other Considerations

  • The American Academy of Sleep Medicine recommends evaluating for comorbid sleep disorders, such as obstructive sleep apnea (OSA) and restless legs syndrome (RLS), which may require specific treatment 4
  • The American Geriatrics Society suggests assessing for medications that may disrupt sleep, such as β-blockers, bronchodilators, corticosteroids, decongestants, diuretics, SSRIs, and SNRIs, and considering low-dose melatonin (1-2mg) taken 1-2 hours before bedtime 5

Common Pitfalls to Avoid

  • The American Geriatrics Society recommends avoiding traditional benzodiazepines due to higher risk of adverse effects in older adults, such as falls, cognitive impairment, and dependence 5
  • The American Academy of Sleep Medicine suggests that sleep hygiene education alone is usually insufficient for treating chronic insomnia, and pharmacological treatments should be limited to short-term use when possible 4
  • The American Academy of Sleep Medicine recommends avoiding over-the-counter antihistamines and sedating antidepressants due to limited evidence for efficacy and higher risk of side effects in older adults 4

Follow-up and Monitoring

  • The American Academy of Sleep Medicine recommends reassessing sleep patterns using sleep logs after 2-4 weeks of intervention, evaluating improvement in sleep efficiency, total sleep time, and daytime functioning, and considering referral to a sleep specialist if insomnia persists despite these interventions 4